| Previous Close | 18.52 |
| Open | 18.52 |
| Day High | 18.52 |
| Day Low | 18.06 |
| 52-Week High | 24.33 |
| 52-Week Low | 10.85 |
| Volume | 32,658.6 |
| Average Volume | 366,745 |
| Market Cap | 686.71M |
| PE | -11.1 |
| EPS | -1.63 |
| Moving Average 50 Days | 18.53 |
| Moving Average 200 Days | 18.51 |
| Change | -0.42 |
Ceribell to Participate in Upcoming March Investor Conferences
GlobeNewswire Inc.
Feb 18, 2026 9:05 PM GMT
SUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
GlobeNewswire Inc.
Feb 10, 2026 9:05 PM GMT
SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced tha
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
GlobeNewswire Inc.
Jan 05, 2026 1:00 PM GMT
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the hospital settingSUNNYVALE, Calif., Jan. 05, 202